Decavanadate Salts of Cytosine and Metformin: A Combined Experimental-Theoretical Study of Potential Metallodrugs Against Diabetes and Cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Aureliano, 2011, Recent perspectives into the biochemistry of decavanadate, World J. Biol. Chem., 2, 215, 10.4331/wjbc.v2.i10.215
Aureliano, 2016, Decavanadate toxicology and Pharmacological Activities: V10 or V1, Both or None?, Oxid. Med. Cell Longev, 2016, 6103457, 10.1155/2016/6103457
Aureliano, 2017, The role of decavanadate in anti-tumor activity, Glob. J. Cancer Ther, 3, 12, 10.17352/gjct.000015
Aureliano, 2009, Decavanadate (V10O286-) and oxovanadates: oxometalates with many biological activities, J. Inorg. Biochem, 103, 536, 10.1016/j.jinorgbio.2008.11.010
Aureliano, 2014, Decavanadate in vitro and in vivo effects: facts and opinions, J. Inorg. Biochem, 137, 123, 10.1016/j.jinorgbio.2014.05.002
Aureliano, 2016, Characterization of decavanadate and decaniobate solutions by Raman spectroscopy, Dalton Trans, 45, 7391, 10.1039/C5DT04176G
Ayed, 2015, Synthesis and structural characterization of new inorganic–organic hybrid: arsenomolybdate compound with cytosinium cations, Bull. Mater. Sci, 38, 13, 10.1007/s12034-014-0805-8
Barone, 1998, Geometry optimization of molecular structures in solution by the polarizable continuum model, J. Comput. Chem, 19, 404, 10.1002/(SICI)1096-987X(199803)19:4<404::AID-JCC3>3.0.CO;2-W
Bartošová, 2012, Synthesis and crystal structure of two copper (II) complexes with coordinated decavanadate ion, Polyhedron, 31, 565, 10.1016/j.poly.2011.10.042
Benmessaoud, 2016, Solvent screening and crystal habit of metformin hydrochloride, J. Cryst. Growth, 451, 42, 10.1016/j.jcrysgro.2016.07.001
Bijelic, 2018, Polyoxometalates as potential next-generation metallodrugs in the combat against cancer, Angewante Chem. Int Ed., 10.1002/anie.201803868.
Bošnjakovic-Pavlovic, 2009, Electronic properties of a cytosine decavanadate: toward a better understanding of chemical and biological properties of decavanadates, Inorg. Chem, 48, 9742, 10.1021/ic9008575
Cafferty, 2016, Spontaneous formation and base pairing of plausible prebiotic nucleotides in water, Nat. Commun., 7, 11328, 10.1038/ncomms11328
Cantley, 1977, Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle, J Biol Chem, 252, 7421, 10.1016/S0021-9258(17)40978-1
Chatkon, 2014, Guanylurea metformium double salt of decavanadate,(HGU+)4(HMet+)2(V10O286–)·2H2O, Inorg. Chim. Acta, 420, 85, 10.1016/j.ica.2013.12.031
Chatkon, 2013, Counterion affects interaction with interfaces: the antidiabetic drugs metformin and decavanadate, Eur. J. Inorg. Chem, 2013, 1859, 10.1002/ejic.201201345
Childs, 2004, A metastable polymorph of metformin hydrochloride: isolation and characterization using capillary crystallization and thermal microscopy techniques, Cryst. Growth Des, 4, 441, 10.1021/cg034243p
Chinea, 2000, Synthesis and characterization of (NH4)4[H4V10O28][NTPH2]2·4H2O (NTPH3 = N(CH2CH2COOH)3), Inorg. Chim. Acta, 298, 172, 10.1016/S0020-1693(99)00440-5
Correia, 2004, Structural studies of decavanadate compounds with organic molecules and inorganic ions in their crystal packing, Inorg. Chim. Acta, 357, 4476, 10.1016/j.ica.2004.06.055
Costa-Pessoa, 2015, adium compounds in medicine, Coord. Chem. Rev, 301, 24, 10.1016/j.ccr.2014.12.002
Crans, 2000, Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds, J. Inorg. Biochem, 80, 123, 10.1016/S0162-0134(00)00048-9
Crans, 2015, Antidiabetic, chemical, and physical properties of organic vanadates as presumed transition-state inhibitors for phosphatases, J. Org. Chem, 80, 11899, 10.1021/acs.joc.5b02229
Del Carpio, 2018, Vanadium: history, chemistry, interactions with α-amino acids and potential therapeutic applications, Coord. Chem. Rev, 372, 117, 10.1016/j.ccr.2018.06.002
Dennington, 2016, Gauss View, Version 6.0.16
Dissem, 2018, A robust framework based on polymeric octamolybdate anions and copper (ii) complexes of tetradentate N-donor ligands, Crystals, 8, 20, 10.3390/cryst8010020
Dolomanov, 2009, OLEX2: a complete structure solution, refinement, and analysis program, J. Appl. Crys, 42, 339, 10.1107/S0021889808042726
Dong, 2015, Crystal structure of bis {2-[amino (iminiumyl) methyl]-1, 1-dimethylguanidine} carbonate methanol disolvate, Acta Crys. E, 71, o747, 10.1107/S2056989015016771
Dorsey, 2018, Evidence that speciation of oxovanadium complexes does not solely account for inhibition of leishmania acid phosphatases, Front. Chemi., 6, 109, 10.3389/fchem.2018.00109
Elberg, 1997, Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes, Diabetes, 46, 16841690, 10.2337/diab.46.11.1684
El-Mir, 2000, Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I, J. Biol. Chem, 275, 223, 10.1074/jbc.275.1.223
Etter, 1990, Graph-set analysis of hydrogen-bond patterns in organic crystals, Acta Crys. B, 46, 256, 10.1107/S0108768189012929
Evans, 2005, Metformin and reduced risk of cancer in diabetic patients, Brit. Med. J, 330, 1304, 10.1136/bmj.38415.708634.F7
Frisch, 2016, Gaussian 16, Revision B.01
Frost, 2005, Raman and infrared spectroscopy of selected vanadates, Spectrochim. Acta A, 61, 829, 10.1016/j.saa.2004.06.006
Frost, 2011, Raman spectroscopic study of pascoite Ca3V10O28·17H2O, Spectrochim. Acta A, 78, 248, 10.1016/j.saa.2010.10.002
Gadape, 2011, Quantitative determination and validation of metformin hydrochloride in pharmaceutical using quantitative nuclear magnetic resonance spectroscopy, J. Chem., 8, 767, 10.1155/2011/461898
Ghasemi, 2018, Glycine and metformin as new counter ions for mono and dinuclear vanadium (V)-dipicolinic acid complexes based on the insulin-enhancing anions: synthesis, spectroscopic characterization, and crystal structure, J. Mol. Struct, 1154, 319, 10.1016/j.molstruc.2017.10.055
Grimme, 2011, Effect of the damping function in dispersion corrected density functional theory, J. Comput. Chem, 32, 1456, 10.1002/jcc.21759
GunasekaranS. NatarajanR. K. RenganayakiV. NatarajanS. Vibrational Spectra and Thermodynamic Analysis of Metformin2006
Hay, 1985, Ab initio effective core potentials for molecular calculations. Potentials for the transition metal atoms Sc to Hg, J. Chem. Phys, 82, 270, 10.1063/1.448799
Hayashi, 2011, Hetero and lacunary polyoxovanadate chemistry: synthesis, reactivity, and structural aspects, Coord. Chem. Rev, 255, 2270, 10.1016/j.ccr.2011.02.013
Ibrahim, 2015, Insulin-like action of novel metformin-containing vanadate as a new antidiabetic drug: synthesis, characterization, and crystal structure of [Metformin-H]2[V2O6]·H2O, J. Mol. Struct, 1098, 92, 10.1016/j.molstruc.2015.05.050
Iyer, 2014, Ligand-mediated valence fultuation of copper in new hybrid materials constructed from decavanadate and a Cu(1,10-phenanthroline) complex, Dalton Trans, 43, 2153, 10.1039/C3DT52484A
Kasznicki, 2014, Metformin in cancer prevention and therapy, Ann. Transl. Med, 2, 57, 10.3978/j.issn.2305-5839.2014.06.01
Kathuria, 2018, “What's in a structure?” The story of biguanides, J. Mol. Struct, 1152, 61, 10.1016/j.molstruc.2017.08.100
Kioseoglou, 2013, Binary decavanadate-betaine composite materials of potential anticarcinogenic activity, Z. Anorg. Allg. Chem, 639, 1407, 10.1002/zaac.201300144
Kojima, 2011, Solvent-driven association and dissociation of the hydrogen-bonded protonated decavanadates, J. Am. Chem. Soc, 133, 7248, 10.1021/ja110781f
Lee, 2010, Screening, manufacturing, photoluminescence, and molecular recognition of co-crystals: cytosine with dicarboxylic acids, Cryst. Growth Des, 10, 1419, 10.1021/cg901412d
Lee, 2003, Potassium–sodium double salt of decavanadate, K4Na2 [V10O28]·10H2O, Acta Crys. E, 59, i122, 10.1107/S1600536803016453
Libby, 2009, New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes, Diabetes care, 32, 1620, 10.2337/dc08-2175
Macrae, 2008, Mercury CSD 2.0 - new features for the visualization and investigation of crystal structures, J. Appl. Cryst, 41, 466, 10.1107/S0021889807067908
Madzharova, 2016, Surface-enhanced hyper-Raman spectra of adenine, guanine, cytosine, thymine, and uracil, J. Phys. Chem, 120, 15415, 10.1021/acs.jpcc.6b02753
Mal, 2013, Tetraalkylphosphonium decavanadates: synthesis, structures, and solution properties, Eur. J. Inorg. Chem, 2013, 1960, 10.1002/ejic.201201447
Martín-Caballero, 2016, A robust open framework formed by decavanadate clusters and copper(ii) complexes of macrocyclic polyamines: permanent microporosity and catalytic oxidation of cycloalkanes, Inorg. Chem, 55, 4970, 10.1021/acs.inorgchem.6b00505
Mathlouthi, 1986, FT-IR and laser-Raman spectra of cytosine and cytidine, Carbohydr. Res, 146, 1, 10.1016/0008-6215(86)85019-4
Muggia, 2012, Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine but also gemcitabine, Expert Opin. Investig. Drugs, 21, 403, 10.1517/13543784.2012.666236
Nagazi, 2014, Synthesis, crystal structure and physicochemical proprieties of a cytosine selenomolybdate based on strandberg-type [Se2Mo5O21]4− polyanion, J. Cluster Sci, 25, 627, 10.1007/s10876-013-0658-0
Narla, 2001, In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]), Clin Cancer Res., 7, 2124
Olar, 2010, Prospects for new antimicrobials based on N, N-dimethylbiguanide complexes as effective agents on both planktonic and adhered to microbial strains, Eur. J. Med. Chem, 45, 2868, 10.1016/j.ejmech.2010.03.009
Omri, 2015, Novel decavanadate cluster complexes (HImz)12(V10O28)·2.3H2O: synthesis, characterization, crystal structure, optical and thermal properties, J. Mol. Struct, 1098, 324, 10.1016/j.molstruc.2015.06.011
Ortaboy, 2018, The removal of radioactive strontium ions from aqueous solutions by isotopic exchange using a strontium decavanadate and corresponding mixed oxides, Chem. Eng. J, 344, 194, 10.1016/j.cej.2018.03.069
Orvig, 1995, Reaction chemistry of BMOV, bis (maltolato) oxovanadium (IV), a potent insulin mimetic agent, J. Am. Chem. Soc., 117, 12759, 10.1021/ja00156a013
Parker, 2009, Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer, Chem. Rev, 109, 2880, 10.1021/cr900028p
Pavliuk, 2014, Decavanadates decorated with [Cu(en)2]2+: convenient synthetic route, crystal structures and analysis of vibrational spectra, Polyhedron, 81, 597, 10.1016/j.poly.2014.06.044
Pereira, 2009, Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes, J. Inorg. Biochem, 103, 1687, 10.1016/j.jinorgbio.2009.09.015
Pérez-Fernández, 2013, Structure and thermodynamical properties of metformin salicylate, Cryst. Growth Des, 13, 1780, 10.1021/cg400150f
Perumalla, 2013, Protonation of cytosine: cytosinium vs. hemicytosinium duplexes, Cryst. Growth Des, 13, 429, 10.1021/cg3014915
Rasheed, 2010, Approximate solution of the mode–mode coupling integral: application to cytosine and its deuterated derivative, Spectrochim. Acta A, 77, 446, 10.1016/j.saa.2010.06.015
Rehder, 2011, A possible role for extraterrestrial vanadium in the encounter of life, Coord. Chem. Rev, 255, 2227, 10.1016/j.ccr.2011.04.015
Rehder, 2012, The potentiality of vanadium in medicinal applications, Future Med. Chem, 4, 1823, 10.4155/fmc.12.103
Rehder, , The (biological) speciation of vanadate (V) as revealed by 51V NMR: a tribute on Lage Pettersson and his work, J. Inorg. Biochem, 147, 25, 10.1016/j.jinorgbio.2014.12.014
Repišcák, 2014, Biomolecular mode of action of metformin in relation to its copper binding properties, Biochemistry, 53, 787, 10.1021/bi401444n
Riou, 1998, Evidence for the solid state structural transformation of the network-type decavanadate (NC7H14)4[H2V10O28] into a lamellar topology (NC7H14)[V4O10]. Z. Anorg. Allg, Chem, 4, 63, 10.1002/(SICI)1521-3749(199806)62
Rozenberg, 2004, Low-temperature FTIR spectroscopy and hydrogen bonding in cytosine polycrystals. Spectrochim, Acta A, 60, 463, 10.1016/S1386-1425(03)00251-8
Sánchez-Lara, , Metforminium decavanadates as a potential metallodrugs in the treatment of cancer and diabetes, V Latinamerican Metting on Biological Inorganic Chemistry
Sánchez-Lara, , Synthesis and 3D network architecture of 1-and 16-hydrated salts of 4-dimethylaminopyridinium decavanadate,(DMAPH)6[V10O28]· nH2O, Crystals, 6, 65, 10.3390/cryst6060065
Sánchez-Lara, 2015, A new dicationic ring [(Water)6–(Ammonium)2] acts as a building block for a supramolecular 3D assembly of decavanadate clusters and 4-(N,Ndimethylamino) pyridinium Ions, J. Cluster Sci, 26, 901, 10.1007/s10876-014-0779-0
Sánchez-Lombardo, 2014, Synthesis of metforminium (2+) decavanadates–crystal structures and solid-state characterization, Eur. J. Inorg. Chem, 2014, 4581, 10.1002/ejic.201402277
Selman, 2018, Multi-modal potentiation of oncolytic virotherapy by vanadium compounds, Mol. Ther, 26, 55, 10.1016/j.ymthe.2017.10.014
Biguanide and squaric acid as pH-dependent building blocks in crystal engineering1063110639 SerbM. D. KalfI. EnglertU. 10.1039/C4CE01643BCryst. Eng. Comm162014
Sheela, 2010, FTIR, FT Raman and UV-visible spectroscopic analysis on metformin hydrochloride, Asian J. Chem, 22, 5049
Sheldrick, 2015, Crystal structure refinement with SHELXL, Acta Cryst. C, 71, 3, 10.1107/S2053229614024218
Soares, 2007, Vanadium distribution, lipid peroxidation and oxidative stress markers upon decavanadate in vivo admistration, J. Inorg. Biochem, 101, 80, 10.1016/j.jinorgbio.2005.02.023
Sridhar, 2012, Competition between the two-point and three-point synthon in cytosine–carboxylic acid complexes, Cryst. Eng. Comm, 14, 7065, 10.1039/c2ce26076j
Steens, 2010, Hydrolytic cleavage of DNA-model substrates promoted by polyoxovanadates, Dalton Trans., 14, 585, 10.1039/b913471a
Swallow, 1964, The structure of the decavanadate Ion, J. Am. Chem. Soc, 86, 4209, 10.1021/ja01073a070
Thompson, 1984, Dietary vanadyl (IV) sulfate inhibits chemically-induced mammary carcinogenesis, Carcinogenesis, 5, 849, 10.1093/carcin/5.6.849
Treviño, 2018, Pharmacological and toxicological threshold of bisammonium tetrakis 4-(N,N-Dimethylamino) pyridinium decavanadate in a rat model of metabolic syndrome and insulin resistance, Bioinorganic Chem. Appl., 2018, 2151079, 10.1155/2018/2151079
Treviño, 2016, Metforminium decavanadate as a potential metallopharmaceutical drug for the treatment of Diabetes mellitus, Oxid. Med. Cell. Longev, 2016, 6058705, 10.1155/2016/6058705
Treviño, 2015, Hypoglycemic, lipid-lowering and metabolic regulation activities of metforminium decavanadate (H2Metf)3 [V10O28]∙8H2O using hypercaloric-induced carbohydrate and lipid deregulation in wistar rats as biological model, J. Inorg. Biochem., 147, 85, 10.1016/j.jinorgbio.2015.04.002
1998, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), Lancet, 352, 854, 10.1016/S0140-6736(98)07037-8
Vermes, 2000, Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions, J. Antimicrob. Chemother, 46, 171, 10.1093/jac/46.2.171
Vilter, 1984, Peroxidase from Phaeophyceae A Vanadium(V)-dependent peroxidase from Ascophyllum nodosum, Phytochemistry, 23, 1387, 10.1016/S0031-9422(00)80471-9
Weng, 2002, A nucleobase–inorganic hybrid polymer consisting of copper bis (phosphopentamolybdate) and cytosine, J. Chem. Soc. Dalton Trans, 3, 289, 10.1039/b111457n
Winkler, 2017, Electron cryo microscopy structure of a human TRPM4 channel, Nature, 552, 200, 10.1038/nature24674
Yraola, 2007, Understanding the mechanism of action of the novel SSAO substrate (C7NH10) 6(V10O28)· 2H2O, a prodrug of peroxovanadate insulin mimetics, Chem. Biol. Drug.Des, 69, 423, 10.1111/j.1747-0285.2007.00516.x
Zhu, 2002, Bis (1, 1-dimethylbiguanido) nickel (II), Acta Cryst. E, 58, m272, 10.1107/S1600536802007869